Prescribing Stimulants in Huntington's Disease

Contraindications and Risks

• The American Academy of Child and Adolescent Psychiatry practice parameters highlight that stimulants can worsen psychotic symptoms, which may be present in Huntington's disease patients, and require careful consideration in movement disorders and neurological conditions 1

Alternative Treatment Approaches

• The American Academy of Child and Adolescent Psychiatry recommends considering alternative evidence-based approaches for managing HD symptoms, such as antipsychotics, tetrabenazine, and SSRIs, although the strength of evidence for these treatments is not specified 1

Clinical Assessment and Management

• Regular assessment of all three clinical domains (motor, behavioral/psychiatric, and cognitive) is necessary when treating HD patients with any medication, and medications should be adjusted as the disease progresses, with careful evaluation of the risk-benefit ratio on an individual basis, although the specific guideline society is not mentioned in this context 1